PL3074045T3 - Możliwa do rozpylania wodna kompozycja zawierająca triazotan glicerolu - Google Patents

Możliwa do rozpylania wodna kompozycja zawierająca triazotan glicerolu

Info

Publication number
PL3074045T3
PL3074045T3 PL14805887T PL14805887T PL3074045T3 PL 3074045 T3 PL3074045 T3 PL 3074045T3 PL 14805887 T PL14805887 T PL 14805887T PL 14805887 T PL14805887 T PL 14805887T PL 3074045 T3 PL3074045 T3 PL 3074045T3
Authority
PL
Poland
Prior art keywords
aqueous composition
glyceryl trinitrate
sprayable aqueous
sprayable
trinitrate
Prior art date
Application number
PL14805887T
Other languages
English (en)
Inventor
Andreas Gerber
Michaela Gorath
Thomas Zimmeck
Original Assignee
G. Pohl-Boskamp Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G. Pohl-Boskamp Gmbh & Co. Kg filed Critical G. Pohl-Boskamp Gmbh & Co. Kg
Publication of PL3074045T3 publication Critical patent/PL3074045T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14805887T 2013-11-29 2014-11-28 Możliwa do rozpylania wodna kompozycja zawierająca triazotan glicerolu PL3074045T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13005562.7A EP2878310B1 (en) 2013-11-29 2013-11-29 Sprayable aqueous composition comprising glyceryl trinitrate
PCT/EP2014/076020 WO2015079049A1 (en) 2013-11-29 2014-11-28 Sprayable aqueous composition comprising glyceryl trinitrate
EP14805887.8A EP3074045B1 (en) 2013-11-29 2014-11-28 Sprayable aqueous composition comprising glyceryl trinitrate

Publications (1)

Publication Number Publication Date
PL3074045T3 true PL3074045T3 (pl) 2018-03-30

Family

ID=49680784

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14805887T PL3074045T3 (pl) 2013-11-29 2014-11-28 Możliwa do rozpylania wodna kompozycja zawierająca triazotan glicerolu

Country Status (7)

Country Link
US (2) US10034850B2 (pl)
EP (2) EP2878310B1 (pl)
AU (1) AU2014356392B2 (pl)
CA (1) CA2931567C (pl)
ES (1) ES2651492T3 (pl)
PL (1) PL3074045T3 (pl)
WO (1) WO2015079049A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2617494T3 (es) * 2012-05-31 2017-06-19 G. Pohl-Boskamp Gmbh & Co. Kg Inducción de arteriogénesis con un donador de óxido nítrico tal como nitroglicerina
EP2878310B1 (en) * 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
US12050781B2 (en) 2021-11-24 2024-07-30 Seagate Technology Llc Distributed data storage system with bottleneck mitigation
US12070440B2 (en) 2022-06-27 2024-08-27 Permeatus, Inc. Topical formulations of nitroglycerin
WO2025115019A1 (en) 2023-11-30 2025-06-05 Padagis Israel Pharmaceuticals Ltd. Stable nitroglycerin formulations

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (pl) 1962-05-24
GB1205019A (en) 1966-12-07 1970-09-09 Sterwin Ag Improvements in or relating to oral dosage forms
JPS599539B2 (ja) 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
CA1163195A (en) 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
US4542013A (en) 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
DE3237284A1 (de) 1982-10-08 1984-04-12 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Loesungsvermittlerfreie, waessrige nitroglycerinloesung
DE3246081A1 (de) 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
DE3856401D1 (de) 1987-01-23 2000-05-04 Gen Hospital Corp Hydralazin zur topischen Behandlung von Glaukom
JPH0645538B2 (ja) 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
HU199678B (en) * 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
DE4007705C1 (pl) 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
US5370862A (en) 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
DE4018919C2 (de) 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray
DE4026072A1 (de) 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray
DE4038203A1 (de) 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5869082A (en) 1996-04-12 1999-02-09 Flemington Pharmaceutical Corp. Buccal, non-polar spray for nitroglycerin
US20010044584A1 (en) 1997-08-28 2001-11-22 Kensey Kenneth R. In vivo delivery methods and compositions
US20030095925A1 (en) 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
DK1019039T3 (da) 1997-10-03 2002-03-25 Warner Lambert Co Komprimeret nitroglycerintablet og fremgangsmåde til dens fremstilling
US6796966B2 (en) 1997-10-15 2004-09-28 Jeffrey E. Thomas Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
WO1999038472A2 (en) 1998-01-28 1999-08-05 Seatrace Pharmaceuticals Inc Topical vasodilatory gel composition and methods of use and production
US5989529A (en) 1998-11-20 1999-11-23 Schering-Plough Healthcare Products, Inc. Substantive topical composition
IT1303793B1 (it) 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
RU2174838C2 (ru) 1999-11-04 2001-10-20 Ивановская государственная медицинская академия Способ лечения тяжелого бронхообструктивного синдрома у детей раннего возраста
US20020049188A1 (en) 1999-12-15 2002-04-25 Azarnoff Daniel L. Nitroglycerin ointment for treatment of pain associated with anal disease
US6443307B1 (en) 2000-01-25 2002-09-03 Michael D. Burridge Medication dispenser with an internal ejector
AU4916501A (en) 2000-03-14 2001-09-24 Noven Pharmaceuticals, Inc. Packaging materials for transdermal drug delivery systems
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
WO2003000292A1 (en) 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
CA2475376C (en) 2002-02-08 2008-07-22 The Procter & Gamble Company Child resistant sachet
US20050095278A1 (en) 2003-01-14 2005-05-05 Viorel Nicolaescu Use of nitroglycerin to relieve nocturnal muscle cramps
US20040228883A1 (en) 2003-02-21 2004-11-18 Mitchell Karl Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation
EP1648362A4 (en) 2003-07-01 2012-01-11 Todd Maibach THERAPEUTIC AGENTS WITH FILM
US20070053966A1 (en) 2003-10-17 2007-03-08 Robert Ang Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
US7781226B2 (en) 2004-02-27 2010-08-24 The Board Of Regents Of The University Of Texas System Particle on membrane assay system
CA2557814A1 (en) 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
US20080260861A1 (en) 2004-04-07 2008-10-23 The General Hospital Corporation Modulating Lymphatic Function
EP1971344B1 (en) 2006-01-09 2010-09-22 Pantarhei Bioscience B.V. A method of treating an acute vascular disorder
WO2007123955A2 (en) 2006-04-19 2007-11-01 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
JP2010519336A (ja) 2007-02-26 2010-06-03 ルンドベルク,ヨン 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
CN101229148A (zh) 2007-12-28 2008-07-30 天津医科大学 硝酸甘油口腔(舌下)崩解片的制剂及其制备方法
DE102008005484A1 (de) 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
ES2396735T3 (es) 2008-03-05 2013-02-25 Rivopharm Sa Vehículos para el nicorandil con estabilidad mejorada
DE202008007318U1 (de) 2008-03-14 2008-07-31 G. Pohl-Boskamp Gmbh & Co. Kg Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat
US20100184870A1 (en) 2008-03-14 2010-07-22 Rolf Groteluschen Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate
WO2010011650A1 (en) 2008-07-21 2010-01-28 Imi International Medical Innovations (D/B/A Procris Pharmaceuticals) Stable water-based topical pharmaceutical creams and methods of making and using same
EP2378957B1 (en) 2008-12-23 2015-09-30 Charité - Universitätsmedizin Berlin Method and device for monitoring arteriogenesis
CA3130908A1 (en) 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
EP2878310B1 (en) * 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate

Also Published As

Publication number Publication date
AU2014356392B2 (en) 2019-07-04
EP2878310A1 (en) 2015-06-03
US10034850B2 (en) 2018-07-31
CA2931567A1 (en) 2015-06-04
EP2878310B1 (en) 2017-01-11
WO2015079049A1 (en) 2015-06-04
EP3074045B1 (en) 2017-09-06
EP3074045A1 (en) 2016-10-05
CA2931567C (en) 2020-07-21
ES2651492T3 (es) 2018-01-26
US10987332B2 (en) 2021-04-27
US20190008815A1 (en) 2019-01-10
AU2014356392A1 (en) 2016-06-09
US20160296488A1 (en) 2016-10-13

Similar Documents

Publication Publication Date Title
IL287109A (en) Pharmaceutical preparations containing dimethyl fumarate
IL274024A (en) Oral preparations
GB2520581B (en) Fragrance composition
PL3030262T3 (pl) Złożona kompozycja farmaceutyczna
GB201319791D0 (en) Formulations
EP2968108A4 (en) COSMETIC COMPOSITIONS
GB201301895D0 (en) Pharmaceutical compositions
IL241378A0 (en) Pharmaceutical preparations
FI3051945T3 (fi) Fungisidiset koostumukset
PL3080225T3 (pl) Wodna kompozycja kleju
GB201319792D0 (en) Formulations
ZA201507717B (en) Composition comprising salbutamol sulphate
GB2516838B (en) Fungicidal compositions and their use
EP3004265A4 (en) Aqueous composition
PL2992120T3 (pl) Kompozycja stopu
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
EP2943067A4 (en) FUNGICIDE COMPOSITION
AP2015008890A0 (en) Pharmaceutical compositions
GB201313688D0 (en) Improved cyanoacrylate compositions
PT2978426T (pt) Composição de tigeciclina estável
GB201307535D0 (en) Alloy composition
GB201304699D0 (en) Pharmaceutical compositions
GB201320742D0 (en) Mist-er spray
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions